SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Indications -- Psoriasis/Chronic Inflammation
An SI Board Since February 2001
Posts SubjectMarks Bans
631 42 0
Emcee:  scaram(o)uche Type:  Moderated
Introduction Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
331<i>The data reflect the percentage of patients whose test results were conscaram(o)uche-1/22/2003
330From label: Drug Interactions MTX reduced adalimumab apparent clearance after sMiljenko Zuanic-1/22/2003
329>>If Humira ended is antigenic, neutralizing antibody should be reported iIcebrg-1/20/2003
328Does not look short to me. t1/2 depend on many factors, so it is not uniform forMiljenko Zuanic-1/20/2003
327Humira - Rick. Any opinions on the following which I picked up on Y!. <i>Icebrg-1/20/2003
326I'm enjoying this release,...being an old cell culture folk,... PharmaGap Prusset-1/18/2003
325Again, label concerns?..... it's given with methotrexate, as approved. &scaram(o)uche-1/17/2003
324Rick I just thought that I should mention the claims that J&J made recentlyIcebrg-1/17/2003
323The results are much better than I expected. And this is right up my alley. I scaram(o)uche-1/17/2003
322Appears the battle is on.... thestreet.comArthur Radley-1/17/2003
321the entire release, with extras....... Amgen Announces Positive Results of Phasscaram(o)uche-1/17/2003
320Amgen Announces Positive Results of Phase 3 ENBREL(R) Study in Psoriasis Friday Arthur Radley-1/17/2003
319AGIX-4207 for RA [Anti "TNF-alpha-inducible genes] Supposedly AGIX-4207, btuck-1/14/2003
318REMICADE FOR SJOGREN SYNDROME ARTHRITIS AND RHEUMATISM, December 2002;46:3301-3Icebrg-1/13/2003
317<i>[ D2E7 approved by FDA ]</i> Happy New Year !nigel bates-1/1/2003
316[ D2E7 approved by FDA ] Abbott Laboratories Receives FDA Approval Earlier Thanscaram(o)uche-12/31/2002
315Genentech regulatory gets past another big hurdle, and the battle is joined. Noscaram(o)uche-12/23/2002
314Hi Miljenko. Don't bet on it (:>)... (eom)fred hayes-12/23/2002
313Now, DNA have some chance to reach market before BGEN (50:50). Press Release SoMiljenko Zuanic-12/23/2002
312Thanks Rick! eomfred hayes-12/18/2002
311Fred: I was just (in part) joking. I'm diversified enough so that I can doscaram(o)uche-12/18/2002
310>>[ anti-alpha-1/BGEN sells ELN down river ]<< Got my attention, bufred hayes-12/18/2002
309Peptech / anti-TNF Wednesday December 18, 3:42 am ET SYDNEY -(Dow Jones)- Peptnigel bates-12/18/2002
308[ anti-alpha-1/BGEN sells ELN down river ] :-) Biogen Scientists Advance Underscaram(o)uche-12/17/2002
307[ humanized anti-CCR2/MLNM ] Message 18340356scaram(o)uche-12/16/2002
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News